炎症性肠病患者抗TNF治疗中出现矛盾性关节炎:复杂滑膜炎的组织学与免疫学特征
本研究纳入10例炎症性肠病(IBD)患者,这些患者在肿瘤坏死因子抑制剂(TNF-i)治疗期间出现矛盾性关节炎,且既往无关节受累史。对配对的滑膜组织(ST)和结肠黏膜(CM)行免疫组化检测,并与银屑病关节炎(PsA)及ACPA/IgM-RF/IgA-RF阴性类风湿关节炎(RA)比较。结果显示,IBD矛盾性关节炎的滑膜组织学特征更接近PsA而非ACPA/IgM-RF/IgA-RF阴性RA;加用传统改善病情抗风湿药及换用乌司奴单抗比换用另一种TNF-i更有效。
要点
- IBD患者TNF-i治疗中出现矛盾性关节炎的滑膜免疫组化特征(CD68+、CD21+、CD20+、CD3+、CD117+细胞)更接近PsA而非ACPA/IgM-RF/IgA-RF阴性RA。
- IBD患者结肠黏膜在內镜下缓解时仍可见CD68+、CD3+、CD117+、CD20+细胞,分别见于100%、70%、60%、50%的病例。
- 加用传统改善病情抗风湿药及换用乌司奴单抗比换用另一种TNF-i更有效。
核心结论
- IBD患者在接受TNF-i治疗期间可出现组织学证实的滑膜炎,其滑膜特征与PsA相当。
- 抑制TNF以外的炎症通路(IL12/IL23)可能是严重矛盾性关节表现的有效治疗选择。
研究设计与样本
- 纳入10例无关节受累史的IBD患者,这些患者在TNF-i治疗期间出现关节炎,每例接受滑膜组织活检及回结肠镜检查并取结肠黏膜活检。
- 滑膜组织和结肠黏膜配对样本通过免疫组化染色检测CD68、CD21、CD20、CD3和CD117。
- 收集临床及免疫学参数(ACPA-IgM/IgA、RF),并以PsA和ACPA/IgM-RF/IgA-RF阴性RA作为对照。
主要发现
- 10例IBD患者年龄46.0±9.7岁,病程13.2±9.9年,TNF-i暴露时间2.5±1.6年,其中6例克罗恩病、4例溃疡性结肠炎。
- 滑膜水平免疫组化显示,IBD矛盾性关节炎患者的滑膜CD68+、CD21+、CD20+、CD3+和CD117+细胞组织学表现与PsA更相似,而与ACPA/IgM-RF/IgA-RF阴性RA不相似。
- 结肠黏膜标本中,IBD患者CD68+、CD3+、CD117+和CD20+细胞分别见于100%、70%、60%和50%的病例,尽管内镜下缓解。
- 加用传统改善病情抗风湿药及换用乌司奴单抗比换用另一种TNF-i更有效。
关键数值与推荐
- 滑膜免疫组化检测标志物包括CD68、CD21、CD20、CD3和CD117。
- 免疫学参数包括ACPA-IgM/IgA和RF。
- 结肠黏膜CD68+、CD3+、CD117+、CD20+细胞阳性率分别为100%、70%、60%、50%。
临床怎么用
- 作者认为,抑制TNF以外的炎症通路(IL12/IL23)可能是严重矛盾性关节表现的有效治疗选择。
- 研究显示加用传统改善病情抗风湿药及换用乌司奴单抗比换用另一种TNF-i更有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Paradoxical arthritis under tumour necrosis factor inhibitor (TNF-i) for inflammatory bowel disease (IBD) has been described. This study aims to evaluate the histological features of paired synovial tissue (ST) and colonic mucosa (CM) tissue in patients with IBD developing paradoxical arthritis under TNF-i. METHODS: Patients with IBD without history of coexisting joint involvement who developed arthritis under TNF-i were enrolled. Each patient underwent ST biopsy and ileocolonoscopy with CM biopsies. ST and CM paired samples were stained through immunohistochemistry (IHC) for CD68, CD21, CD20, CD3 and CD117. Clinical and immunological parameters (anticitrullinated peptides antibodies (ACPA)-immunoglobulin (Ig)M/IgA rheumatoid factor (RF)) were collected. Psoriatic arthritis (PsA) and ACPA/IgM-RF/IgA-RF negative rheumatoid arthritis (RA) were enrolled as comparison. RESULTS: 10 patients with IBD (age 46.0±9.7 years, 13.2±9.9 years of disease duration, 2.5±1.6 years of TNF-i exposure, six with Crohn's disease and four with ulcerative colitis, respectively) were studied. At ST level, IHC revealed that patients with IBD with paradoxical arthritis showed more similar histological findings in terms of synovial CD68+, CD21+, CD20+, CD3+ and CD117+ cells compared with PsA than ACPA/IgM-RF/IgA-RF negative RA. Analysing the CM specimens, patients with IBD showed the presence of CD68+, CD3+, CD117+ and CD20+ cells in 100%, 70%, 60% and 50% of cases, respectively, despite endoscopic remission. Finally, addition of conventional disease-modifying antirheumatic drugs and switch to ustekinumab were more effective than swapping into different TNF-i in patients with IBD with paradoxical arthritis. CONCLUSION: Patients with IBD may develop histologically proven synovitis during TNF-i, comparable to PsA. The inhibition of inflammatory pathways alternative to TNF (IL12/1L23) may be an effective therapeutic option for severe paradoxical articular manifestations.
引用
- Alivernini S, Pugliese D, Tolusso B, et al. Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis. RMD Open. 2018. PMID: 29657833. doi:10.1136/rmdopen-2018-000667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。